VSee Health Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

Reuters
Aug 29, 2025
<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. Reports 81% Increase in Revenue for 2024, Net Loss Widens Significantly to $57.7 Million

VSee Health Inc. reported significant financial results for the fiscal year ending December 31, 2024. The company achieved revenues of $10.4 million, representing an 81% increase compared to $5.8 million in 2023. Despite this growth in revenue, VSee Health recorded a net loss of $57.7 million, a substantial increase from the net loss of $3.7 million in the prior year. The gross margin for VSee Health rose to $7.2 million, up from $3.8 million the previous year, marking an 87% improvement. Operating expenses soared to $69.3 million from $5.7 million, a significant rise that impacted the company's bottom line. In terms of other income and expenses, VSee Health reported a net gain of $2.8 million compared to a slight loss of $13,375 in the prior year. The company also noted an income tax benefit of $1.6 million, contrasting with a provision of $1.8 million the year before. Business operations continue to focus on generating revenue through subscription services to its software platform via its subsidiary, VSee Lab. The company has adjusted its financial statements, reflecting restatement adjustments in its financial analysis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011813), on August 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10